NCT05298748 The Effect of Womb Recordings on Maturation of Respiratory Control in Preterm Infants
| NCT ID | NCT05298748 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Case Western Reserve University |
| Condition | Apnea of Prematurity |
| Study Type | INTERVENTIONAL |
| Enrollment | 34 participants |
| Start Date | 2022-09-16 |
| Primary Completion | 2026-10 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 34 participants in total. It began in 2022-09-16 with a primary completion date of 2026-10.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this proposal is to characterize the acute effect of early postnatal sound exposure on neuronal maturation of the respiratory control regions of the brain in preterm infants.
Eligibility Criteria
Inclusion Criteria: * preterm infants 29-33 weeks gestational age at birth * 34 weeks corrected age * off respiratory support \>1.5 lpm Exclusion Criteria: * on respiratory support \>1.5 lpm * congenital anomalies
Contact & Investigator
Cynthia Bearer, MD
PRINCIPAL INVESTIGATOR
University Hospitals Cleveland Medical Center
Frequently Asked Questions
Who can join the NCT05298748 clinical trial?
This trial is open to participants of all sexes, aged 1 Week or older, up to 5 Weeks, studying Apnea of Prematurity. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05298748 currently recruiting?
Yes, NCT05298748 is actively recruiting participants. Contact the research team at Cynthia.Bearer@UHhospitals.org for enrollment information.
Where is the NCT05298748 trial being conducted?
This trial is being conducted at Cleveland, United States.
Who is sponsoring the NCT05298748 clinical trial?
NCT05298748 is sponsored by Case Western Reserve University. The principal investigator is Cynthia Bearer, MD at University Hospitals Cleveland Medical Center. The trial plans to enroll 34 participants.